Sodium levofolinate product and preparation method thereof

A technology of sodium levofolinate and sodium levofolinate oral liquid, which is applied in the directions of pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc. Preservation, damage to the skin and blood vessels of the patient, and the inability of the patient to take it normally, to achieve the effect of convenient transportation and storage, improving quality and ensuring drug efficacy

Pending Publication Date: 2021-11-23
深圳市资福药业有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, patients are usually injected with sodium leucovorin by injection, and long-term injection will cause damage to the skin and blood vessels of the patient, which is not conducive to the normal recovery of the patient. In the clinical application of the product, it often occurs that patients cannot take it normally, and in the process of transportation and storage, the existing sodium levofolinate solution cannot be stored stably. In view of this, we propose a levofolinic acid solution Sodium products and methods for their preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The present invention provides a technical solution: a sodium leucovorin product, including sodium leucovorin raw materials, the raw materials of the sodium leucovorin product are realized by the following mass ratio:

[0030] 5 parts of sodium levofolinate, 20-25 parts of lactose solution, 2 parts of talcum powder, 10-15 parts of stabilizer, 10-12 parts of fragrance stock solution, 12-14 parts of protective agent and 5 parts of yam protein mixed powder.

[0031] The sodium leucovorin and lactose solution are mixed to prepare the sodium folinate oral liquid base liquid, the talcum powder and the stabilizer are used to obtain the stabilizer base liquid, and the protecting agent and yam protein mixed powder are prepared to obtain the protectant base liquid , the stabilizing agent is made by mixing mint honey, pineapple juice and honey, and the ratio of the mass of mint honey, pineapple juice and honey is 1:2:2, and the protecting agent is made of pregelatinized starch and ...

Embodiment 2

[0044] The present invention provides a technical solution: a sodium leucovorin product, including sodium leucovorin raw materials, the raw materials of the sodium leucovorin product are realized by the following mass ratio:

[0045] 5 parts of sodium levofolinate, 20-25 parts of lactose solution, 2 parts of talcum powder, 10-15 parts of stabilizer, 10-12 parts of fragrance stock solution, 12-14 parts of protective agent and 5 parts of yam protein mixed powder.

[0046] The sodium leucovorin and lactose solution are mixed to prepare the sodium folinate oral liquid base liquid, the talcum powder and the stabilizer are used to obtain the stabilizer base liquid, and the protecting agent and yam protein mixed powder are prepared to obtain the protectant base liquid , the stabilizing agent is made by mixing mint honey, pineapple juice and honey, and the ratio of the mass of mint honey, pineapple juice and honey is 1:2:2, and the protecting agent is made of pregelatinized starch and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a sodium levofolinate product and a preparation method thereof, and relates to the technical field of medicine production. The sodium levofolinate product comprises a sodium levofolinate product raw material, and the sodium levofolinate product raw material is prepared from, by mass, 5 parts of sodium levofolinate, 20-25 parts of a lactose solution, 2 parts of talcum powder, 10-15 parts of a stabilizing agent, 10-12 parts of a fragrant stock solution, 12-14 parts of a protective agent and 5 parts of Chinese yam protein mixed powder. The sodium levofolinate and the lactose solution are mixed to prepare a basic solution of the sodium levofolinate oral liquid. According to the sodium levofolinate product and the preparation method thereof, by adding the stabilizing agent and the protective agent, the stability of the sodium levofolinate oral liquid can be effectively improved, so that the produced sodium levofolinate oral liquid can be stored more stably for a long time and is convenient to transport and store; the sodium levofolinate oral liquid is pressurized, the stability is higher, the drug effect of the sodium folinate oral liquid can be effectively guaranteed, and the quality of the sodium folinate oral liquid is further improved.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical production, in particular to a sodium levofolinate product and a preparation method thereof. Background technique [0002] Malignant tumors have become one of the most common diseases in our country. With population aging, urban population growth, and environmental degradation, the incidence and death toll of cancer will continue to increase across the country. Although cancer has a high mortality rate, it is not incurable. With the development of chemotherapy, radiotherapy and other treatment methods, the five-year survival rate of cancer patients is increasing year by year. At present, chemotherapy is one of the main means of comprehensive tumor treatment. With the continuous emergence of new chemotherapy drugs and adjuvant chemotherapy drugs, how to reasonably select and match various anti-tumor drug resources will improve the cure rate and prolong the survival of patients. Improving ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/519A61K47/46A61K47/36A61K47/18A61K47/10A61K47/02A61P35/00
CPCA61K9/0095A61K31/519A61K47/46A61K47/36A61K47/183A61K47/10A61K47/02A61P35/00
Inventor 姜海兵
Owner 深圳市资福药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products